rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1994-9-30
|
pubmed:abstractText |
Non-A, non-B acute hepatitis progresses to a higher incidence of chronicity and hepatocellular carcinoma. To avoid the development of chronic liver disease, resolution of acute hepatitis C might be most effective. The aim was to establish the effect of interferon in disturbing progression to chronicity and to determine the most appropriate treatment protocol.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0016-5085
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
107
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
805-11
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8076768-Adult,
pubmed-meshheading:8076768-Aged,
pubmed-meshheading:8076768-Dose-Response Relationship, Drug,
pubmed-meshheading:8076768-Female,
pubmed-meshheading:8076768-Genotype,
pubmed-meshheading:8076768-Hepacivirus,
pubmed-meshheading:8076768-Hepatitis Antibodies,
pubmed-meshheading:8076768-Hepatitis C,
pubmed-meshheading:8076768-Humans,
pubmed-meshheading:8076768-Immunoenzyme Techniques,
pubmed-meshheading:8076768-Interferon-beta,
pubmed-meshheading:8076768-Male,
pubmed-meshheading:8076768-Middle Aged,
pubmed-meshheading:8076768-Prospective Studies,
pubmed-meshheading:8076768-RNA, Viral,
pubmed-meshheading:8076768-Sensitivity and Specificity
|
pubmed:year |
1994
|
pubmed:articleTitle |
Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group.
|
pubmed:affiliation |
Division of Gastroenterology and Hepatology, Kawasaki Chuo Hospital, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|